Through coordinated GLP-1R and GIPR activation, tirzepatide enhances glucose-dependent insulin secretion, improves glycemic control, contributes to lipid homeostasis, and reduces appetite and food intake, supporting its clinical use in obesity and type 2 diabetes [13]
Pre-clinical wound-healing models report that GHK-Cu accelerates closure and improves tensile strength through a combination of fibroblast activation, angiogenic signaling, macrophage recruitment, and matrix-protein synthesis
Most physicians recommend introducing one compound before the other rather than starting both simultaneously
Are Intranasal Drugs the Future for ME/CFS and Fibromyalgia
1-Palmitoyl-2-(13-hydroxy-cis-9,trans-11-octadecadienoyl)-L-3-phosphatidylcholine 1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC is an oxidized phospholipid that contains palmitic acid and 13(S)-HODE at the sn-1 and sn-2 positions, respectively